Advertisement
Canada markets close in 6 hours 18 minutes

  • S&P/TSX

    22,018.19
    +6.47 (+0.03%)
     

  • S&P 500

    5,086.99
    +16.44 (+0.32%)
     

  • DOW

    38,459.99
    -43.70 (-0.11%)
     

  • CAD/USD

    0.7300
    -0.0020 (-0.28%)
     

  • CRUDE OIL

    82.87
    -0.49 (-0.59%)
     

  • Bitcoin CAD

    90,661.19
    -308.68 (-0.34%)
     

  • CMC Crypto 200

    1,427.50
    +3.40 (+0.24%)
     

  • GOLD FUTURES

    2,333.90
    -8.20 (-0.35%)
     

  • RUSSELL 2000

    2,002.64
    +35.17 (+1.79%)
     

  • 10-Yr Bond

    4.6380
    +0.0400 (+0.87%)
     

  • NASDAQ

    15,830.04
    +133.40 (+0.85%)
     

  • VOLATILITY

    15.89
    +0.20 (+1.28%)
     

  • FTSE

    8,073.03
    +28.22 (+0.35%)
     

  • NIKKEI 225

    38,460.08
    +907.92 (+2.42%)
     

  • CAD/EUR

    0.6819
    -0.0017 (-0.25%)
     
MARKETS LIVE BLOG:

STOCKS OPEN MIXED, TESLA SURGES DAY AFTER EARNINGS

Tesla shares jump after EV maker vows to speed up launch of more affordable models

Today's Research Reports on Aurinia Pharmaceuticals, Canopy Growth, Knight Therapeutics and Covalon Technologies

ACCESSWIRE

NEW YORK, NY / ACCESSWIRE / September 24, 2018 / Research Driven Investing strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register with us free at http://rdinvesting.com and get exclusive access to our numerous research reports and market updates.

RDI Initiates Coverage on:

Aurinia Pharmaceuticals Inc.
https://rdinvesting.com/news/?ticker=AUP.TO

Canopy Growth Corporation
https://rdinvesting.com/news/?ticker=WEED.TO

Knight Therapeutics Inc.
https://rdinvesting.com/news/?ticker=GUD.TO

Covalon Technologies Ltd.
https://rdinvesting.com/news/?ticker=COV.V

ADVERTISEMENT

Aurinia Pharmaceuticals’ stock moved 4.89% lower Friday, to close the day at $7.00. The stock recorded a trading volume of 68,596 shares, which was above its three months average volume of 21,524 shares. In the last year, Aurinia Pharmaceuticals' shares have traded in a range of 5.68 - 9.50. The share price has gained 23.24% from its 52 week low. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $7.17 is lower than its 200-day moving average of $7.22. Shares of Aurinia Pharmaceuticals have gained approximately 22.38 percent year-to-date.

Access RDI's Aurinia Pharmaceuticals Inc. Research Report at:
https://rdinvesting.com/news/?ticker=AUP.TO

On Friday, shares of Canopy Growth recorded a trading volume of 3,951,731 shares, which was below the three months average volume of 6,740,401 shares. The stock ended the day 4.6% lower at $64.46. The share price has fallen 13.42% from its 52 week high with a 52 week trading range of 10.40 - 74.45. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $54.68 is greater than its 200-day moving average of $38.98. Shares of Canopy Growth have gained approximately 116.75 percent year-to-date.

Access RDI's Canopy Growth Corporation Research Report at:
https://rdinvesting.com/news/?ticker=WEED.TO

Knight Therapeutics’ stock moved 1.1% higher Friday, to close the day at $8.29. The stock recorded a trading volume of 95,415 shares, which was above its three months average volume of 94,803 shares. In the last year, Knight Therapeutics' shares have traded in a range of 7.38 - 9.11. The share price has gained 12.33% from its 52 week low. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $8.35 is greater than its 200-day moving average of $8.12. Shares of the company are trading at a Price to Earnings ratio of 54.90. Shares of Knight Therapeutics have fallen approximately 0.24 percent year-to-date.

Access RDI's Knight Therapeutics Inc. Research Report at:
https://rdinvesting.com/news/?ticker=GUD.TO

On Friday, shares of Covalon Technologies recorded a trading volume of 20,088 shares, which was below the three months average volume of 28,562 shares. The stock ended the day 0.66% lower at $9.10. The share price has fallen 3.7% from its 52 week high with a 52 week trading range of 3.22 - 9.45. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $8.12 is greater than its 200-day moving average of $6.67. Shares of the company are trading at a Price to Earnings ratio of 73.98. Shares of Covalon Technologies have gained approximately 86.09 percent year-to-date.

Access RDI's Covalon Technologies Ltd. Research Report at:
https://rdinvesting.com/news/?ticker=COV.V

Our Actionable Research on Aurinia Pharmaceuticals Inc. (TSX:AUP.TO), Canopy Growth Corporation (TSX:WEED.TO), Knight Therapeutics Inc. (TSX:GUD.TO) and Covalon Technologies Ltd. (TSXV:COV.V) can be downloaded free of charge at Research Driven Investing.

Research Driven Investing

We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.

RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.

Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered broker dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

Address:

Email:

contact@rdinvesting.com

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: RDInvesting.com